Shultz C Scott, Dreher Spencer D, Ikemoto Norihiro, Williams J Michael, Grabowski Edward J J, Krska Shane W, Sun Yongkui, Dormer Peter G, Dimichele Lisa
Department of Process Research and the Catalytic Reactions Discovery and Development Lab, Merck and Co Inc., P.O. Box 2000, Rahway, New Jersey 07065.
Org Lett. 2005 Aug 4;7(16):3405-8. doi: 10.1021/ol050869s.
A novel and highly enantioselective Ru-catalyzed hydrogenation of N-sulfonylated-alpha-dehydroamino acids has been discovered and demonstrated in the synthesis of an anthrax lethal factor inhibitor (LFI). Herein, this methodology is used to prepare N-sulfonylated amino acids in up to 98% ee. This unprecedented hydrogenation uses a chiral Ru catalyst rather than Rh as typical for acylated dehydroamino acids and esters, and this work reports the first asymmetric hydrogenation of a tetrasubstituted dehydroamino acid derivative using a Ru catalyst. [reaction: see text]
已发现并在炭疽致死因子抑制剂(LFI)的合成中证明了一种新型且高度对映选择性的钌催化的N-磺酰化-α-脱氢氨基酸氢化反应。在此,该方法用于制备对映体过量高达98%的N-磺酰化氨基酸。这种前所未有的氢化反应使用手性钌催化剂,而不是酰化脱氢氨基酸和酯通常使用的铑催化剂,并且这项工作报道了首次使用钌催化剂对四取代脱氢氨基酸衍生物进行不对称氢化反应。[反应:见正文]